eHealth Inc expected to post earnings of $2.98 a share - Earnings Preview

Reuters
02-24
eHealth Inc <ehth.oq> expected to post earnings of $2.98 a share - Earnings Preview </ehth.oq>
  • eHealth Inc EHTH.OQ EHTH.O is expected to show a rise in quarterly revenue when it reports results on February 26 for the period ending December 31 2024

  • The Austin Texas-based company is expected to report a 14.7% increase in revenue to $284.111 million from $247.66 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data. (SAL majority is on Total Revenue basis)

  • ​LSEG's mean analyst estimate for eHealth Inc is for earnings of $2.98 per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for eHealth Inc is $9.75​, below​ its last closing price of $10.05. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

-1.37

-1.28

-1.47

Missed

-14.4

Jun. 30 2024

-0.86

-0.84

-1.17

Missed

-39.3

Mar. 31 2024

-0.65

-0.62

-0.77

Missed

-24.2​

Dec. 31 2023

1.85

1.84

1.44

Missed

-21.9

​​Sep. 30 2023

-1.41

-1.38

-1.45

Missed

-4.7

Jun. 30 2023

-1.09

-1.11

-0.96

Beat

13.2​

Mar. 31 2023

-0.94

-0.95

-0.83

Beat

12.4

Dec. 31 2022

0.71

0.56

1.14

Beat

103

This summary was machine generated February 24 at 13:52 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10